Home About Us Services ↳ Canada PR Visa (Permanent Residency) ↳ Work Permit Canada ↳ LMIA — Labour Market Impact Assessment ↳ Spouse & Family Sponsorship Visa ↳ Student Visa Canada ↳ Visitor Visa ↳ Business Visa Provinces ↳ 🏙️ Ontario ↳ 🏔️ British Columbia ↳ 🌾 Alberta ↳ 🌻 Saskatchewan ↳ 🌊 Manitoba ↳ ⚓ Nova Scotia ↳ 🍁 New Brunswick ↳ 🦞 Prince Edward Island ↳ 🐟 Newfoundland & Labrador ↳ 🌊 Atlantic Immigration Program Healthcare Blog FAQ Careers Canada Contact

72 Substances identified as being of low concern

These substances were identified for action under the Chemicals Management Plan (CMP). The final screening assessment incorporates results from the Science Approach Document: Ecological Risk Classification of Organic Substances and the Science Approach Document: Threshold of Toxicological Concern (TTC)-based Approach for Certain Substances.

Summary of publications
Final screening assessment Conclusion on section 64 criteria Follow-up activities
HTML Does not meet CAS RNs 111-96-6 and 112-49-2: Significant new activity (SNAc) provisions

Follow-up activities

While exposure to any of the 72 substances is not of concern at current levels, two substances (CAS RNs 111-96-6 and 112-49-2) have been identified as having potential health effect of concern. Therefore, there may be a concern if exposure levels were to increase. For this reason, the Government of Canada has applied the SNAc provisions of the Canadian Environmental Protection Act, 1999 (CEPA) to these two substances.

Information gathering

Section 71 CMP 2026 – Phase 1

In August 2026, a notice was published in the Canada Gazette, Part I: Vol. 160, No. 35 – August 29, 2026, under section 71 of CEPA. This notice applies to one substance included in this substance grouping (CAS RN 3081-14-9). More information is available on the information gathering with respect to certain substances under the CMP web page.

Section 71 CMP 2023

In June 2023, a notice was published in the Canada Gazette, Part I: Vol. 157, No. 25 - June 24, 2023, under section 71 of CEPA. This notice applies to three substances included in this substance grouping (CAS RNs 793-24-8, 27193-86-8, and 68784-26-9). More information is available on the Information gathering with respect to certain substances under the Chemicals Management Plan web page.

Timelines
Date Activity
August 29, 2026 Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA.
June 24, 2023 Publication in Canada Gazette, Part I, of a notice under section 71 of CEPA.
August 3, 2022 Publication in the Canada Gazette, Part II: Vol. 156, No. 16 of an order amending the Domestic Substances List (DSL) to apply the SNAc provisions of the CEPA to CAS RNs 111-96-6 and 112-49-2.
November 3, 2018 Publication in the Canada Gazette, Part I: Vol. 152, No. 44 and start of 60-day public comment period on a notice of intent to amend the DSL to apply the SNAc provisions of CEPA to CAS RNs 111-96-6 and 112-49-2.
November 3, 2018 Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 152, No. 44.
June 17, 2017 Publication and start of 60-day public comment period on the draft screening assessment (including follow-up activities for 36 of the 74 substances). The related notice was published in the Canada Gazette, Part I: Vol. 151, No. 24.

Background

Combining the results from both approaches, 75 substances were identified to be of low concern for human health and ecological risk. One substance (CAS RN 118-96-7) was later found to be associated with an international classification for carcinogenicity based on empirical data with positive results, thereby excluding it from the TTC-based approach. This substance was assessed in the Final Screening Assessment for the Rapid Screening of Substances with Limited General Population Exposure.

Also, as a result of new information on uses and volumes submitted pursuant to a CEPA section 71 notice, two additional substances (CAS RNs 4979-32-2 and 94270-86-7) that were included in the draft of this screening assessment have been removed for further assessment due to potential human health concerns. These substances are being assessed as a part of the Benzotriazoles and Benzothiazoles Group.

Page details

2026-08-28

Quick Enquiry

We usually reply within a few hours
By submitting you agree to be contacted about your enquiry.
Call us Chat on WhatsApp
M

Migova AI Assistant

Online now
Hi 👋 I'm the Migova AI assistant, powered by OpenAI. Ask me about PR, study visas, work permits, LMIA, family sponsorship, provinces, or healthcare immigration to Canada.
Canada PR
Study Visa
LMIA / Work Permit